Mofification of body composition by clenbuterol in normal and dystrophic (mdx) mice
- 1 September 1985
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 5 (9) , 755-760
- https://doi.org/10.1007/bf01119873
Abstract
Female dystrophic mice (mdx on C57 Black background) gained weight more rapidly than age-matched controls and had a higher body fat content (% body weight), a slightly lower protein content and a reduced mass of muscle. Chronic treatment (21 d) of the mice with the β2-agonist clenbuterol stimulated weight gain in both genotypes without affecting energy intake. Clenbuterol increased the mass of the gastrocnemius and soleus muscle by 13% and 29% in normal and dystrophic mice, respectively, and raised body protein but depressed body fat. Body water and energy content were unaffected by clenbuterol, but the ratio of protein to fat in the carcasses was enhanced by 17% in normal and 56% in dystrophic mice following clenbuterol treatment. Thus, the β2-agonist restored the body composition of dystrophic mice to normal and enhanced the protein to fat ratio in both these and normal mice.This publication has 10 references indexed in Scilit:
- Use of a β-Agonist to Alter Fat and Muscle Deposition in Steers1Journal of Animal Science, 1984
- Use of a β-Adrenergic Agonist to Alter Muscle and Fat Deposition in Lambs1Journal of Animal Science, 1984
- X chromosome-linked muscular dystrophy (mdx) in the mouse.Proceedings of the National Academy of Sciences, 1984
- Chronic effects of β2 agonists on body composition and protein synthesis in the ratBioscience Reports, 1984
- Protein synthesis in liver, skeletal muscle, and brown adipose tissue of rats fed a protein-deficient dietBioscience Reports, 1983
- Diet-Induced ThermogenesisPublished by Springer Nature ,1983
- MORPHOLOGICAL CHANGES IN DYSTROPHIC MUSCLEBritish Medical Bulletin, 1980
- ANIMAL MODELS: WHAT IS THEIR RELEVANCE TO THE PATHOGENESIS OF HUMAN MUSCULAR DYSTROPHY?British Medical Bulletin, 1980